Exploring the experiences of patients, general practitioners and oncologists of prostate cancer follow-up: A qualitative interview study.
The Christie Patient Centred Research Team, The Christie School of Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK. Electronic address: [email protected]
The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.
The Christie Patient Centred Research Team, The Christie School of Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.
The Christie Patient Centred Research Team, The Christie School of Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK; Division of Nursing, Midwifery and Social Work, School of Health Sciences, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
- Published Article
European journal of oncology nursing : the official journal of European Oncology Nursing Society
- Publication Date
Oct 01, 2020
To examine the experiences of patients and healthcare professionals of prostate cancer follow-up in primary care and to identify areas where current policy and practice could be improved. Semi-structured interviews with patients, GPs and oncologists explored experiences of prostate cancer follow-up. Interviews were audio recorded and transcribed verbatim. Data were analysed using thematic analysis. The three participant groups were analysed as individual datasets but the same key themes were evident across the groups. 14 patients, 6 GPs and 5 oncologists were interviewed. Four main themes were identified: Experience of current practice; Knowledge and understanding of prostate cancer follow up; Disparity of processes and pathways; Unclear roles and responsibilities. Findings from this study highlight the variation in the approach to prostate specific antigen monitoring and emphasise the lack of clear policies and practices. The lack of clarity around existing follow up and monitoring processes could cause delays in the diagnosis of recurrence. There is a need for a new and improved pathway for prostate cancer follow up. The pathway should include clear and concise guidance for patients, primary care and secondary care and all relevant parties need to understand what their role is within the pathway. Copyright © 2020. Published by Elsevier Ltd.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 02/22/2021 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/32932010